Navigation Links
Vermillion Announces First Quarter 2008 Financial Results and Business Progress
Date:5/15/2008

veloping PAD.

* Further bolstered Vermillion's intellectual property by advancing

the Company's license agreement with Stanford University to an

exclusive level. The license from Stanford covers the development

and commercialization of a biomarker panel used to assess the risk

of PAD.

* Hosted a roundtable teleconference focusing on Vermillion's PAD

diagnostic program and the need for improved detection of this

life- and limb-threatening condition. The teleconference featured

keynote speaker John Cooke, M.D., Ph.D., Professor of Medicine at

Stanford University, whose research forms the basis of Vermillion's

VASCLIR test.

* Conducted market-development activities, including working with the

PAD Coalition and implementing an online physician survey to gather

market-based information, helping to define the Company's

commercialization strategy and broaden future clinical use of

VASCLIR.

-- Ovarian Cancer Diagnostic Program

* Continued to make progress with the clinical study evaluating OVA1

and plan to submit to the FDA in the second quarter.

* Presented data from several studies demonstrating the benefits of

the Company's ovarian cancer diagnostic test programs at the

Society of Gynecologic Oncologists' (SGO) 39th Annual Meeting on

Women's Cancer. The data suggest that use of Vermillion's tests

could help better identify women with early-stage ovarian cancer

and improve detection.

* Received the distinguished SGO Basic Science Poster Award for its

abstract, "Prospective independent validation of a marker panel for

distinguishing benign from malignant pelvic masses."

-- Hematology Diagnostic Program

* Reporte
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... MX (PRWEB) September 18, 2014 September ... Mexico City, MX. ASEA is the manufacturer of the ... the skin care product, RENU28. , The Mexico ... Vice President Duvan Botero, and ASEA Field Leader Shawn ... holds a PhD in Atomic/Medical Physics from the University ...
(Date:9/17/2014)... INCLINE VILLAGE, Nev. , Sept. 17, 2014  PDL ... notified by its independent registered accounting firm, Ernst & Young ... The resignation was confirmed in a letter delivered to the ... 8-K filed on September 16, 2014.  PDL ... "We have received a number of inquiries on ...
(Date:9/17/2014)... -- The global consumption of squalene / squalane is expected ... skin-identical chemical that finds applications in various end user industries ... in other applications like high grade lubrication, and fiber coating ... players and is regionally segregated. Sophim ( France ... ( Japan ), SeaDragon Marine Oils Ltd. ( ...
(Date:9/17/2014)... , Sept. 17, 2014  The In Silico ... that will be featured at the conference, which takes ... on December 3 and 4, 2014. Researchers, students, drug ... to hear the following: KEYNOTE SPEAKERS ... Diego Skaggs School of Pharmacy Drug ...
Breaking Biology Technology:Announcing the ASEA Mexico Grand Opening Tour Beginning September 18th 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 3Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3In Silico Drug Discovery Conference Announces Speakers and Topics 2In Silico Drug Discovery Conference Announces Speakers and Topics 3In Silico Drug Discovery Conference Announces Speakers and Topics 4In Silico Drug Discovery Conference Announces Speakers and Topics 5In Silico Drug Discovery Conference Announces Speakers and Topics 6In Silico Drug Discovery Conference Announces Speakers and Topics 7
... Amgen (Nasdaq: AMGN ) today announced that ... financial results on Monday, Jan. 24, 2011 after the close ... a conference call with the investment community at 2:00 p.m. ... Kevin Sharer, chairman and chief executive officer, and other members ...
... 2011 Sensus Healthcare is pleased to ... professional skin care products to be exclusively offered by ... Cases of skin cancer are on the rise and ... taking new aim at skin cancer (SM) in ...
... 2011 Cephalon, Inc., (Nasdaq: CEPH ) will hold ... founder and late Chairman and CEO on February 1, 2011, at ... Street, Philadelphia, Pennsylvania. Dr. Baldino founded Cephalon in ... one of the top ten biotechnology companies in the world. He ...
Cached Biology Technology:Amgen Announces Webcast of 2010 Fourth Quarter and Full Year Financial Results 2Sensus Healthcare Announces New Professional Skin Care Line - Sensus Skin Solutions™ 2Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D. 2
(Date:9/18/2014)... invisible is probably the ultimate form of camouflage: you ... And this strategy is not as uncommon as you ... Baltimore County, USA, explains that the larval life stages ... one part of the anatomy that most creatures cannot ... eyes have to shield each individual eye unit with ...
(Date:9/17/2014)... UCLA atmospheric scientists were instrumental in the creation of ... tool to classify the fire threat potential of the ... a spark into an inferno. The index was introduced ... with UCLA and San Diego Gas and Electric. , ... to "extreme" that will be used to help fire ...
(Date:9/17/2014)... genetic disorder known as Jacobsen syndrome has been linked ... researchers at San Diego State University and the University ... treatment options for people with Jacobsen syndrome, the finding ... autism., Jacobsen syndrome affects approximately 1 in 100,000 people, ... in a person when there is a deletion at ...
Breaking Biology News(10 mins):Transparent larvae hide opaque eyes behind reflections 2UCLA scientists play key role in developing new Santa Ana Wildfire Threat Index 2A link between Jacobsen syndrome and autism 2
... is difficult to measure accurately each nation,s contribution of carbon ... the ground as coal, gas, and oil, and these fuels ... to generate the energy that is used to make products. ... countries where they are consumed. A team led by Carnegie,s ...
... The University of Texas at Austin whose technology developments in ... tens of thousands of patients with diseases such as cancer ... Institute of Medicine (IOM). Established in 1970, IOM is ... institute is considered one of the highest honors in health ...
... of spinal cord injury is receiving attention in the ... the department of biomedical engineering at NJIT, recently has ... micro-electrical stimulators for individuals with spinal cord injuries. ... year of support from a four-year, $1.4 million National ...
Cached Biology News:Links in the chain: Global carbon emissions and consumption 2UT professor elected to the Institute of Medicine of the National Academies 2UT professor elected to the Institute of Medicine of the National Academies 3NJIT researcher testing micro-electronic stimulators for spinal cord injuries 2
Rat CINC-2 alpha/beta Affinity Purified Polyclonal Ab...
Tachykinin (H-2)...
...
... to significantly increase the shelf life of ... increased at room temperature storage conditions in ... is subjected to 0.45 micron filtration, and ... formulation insures consistently high levels of activity ...
Biology Products: